Picture Stier Group MIXiii Lifescience Healthtech Conference 650x100px
Document › Details

Lipotype GmbH. (9/13/17). "Press Release: Lipid Analysis for Early Stages of Drug Discovery – Customer Reference Flagship VentureLabs".

Organisations Organisation Lipotype GmbH
  Organisation 2 Flagship VentureLabs
  Group Flagship Pioneering
Products Product mass spectrometry services (MS services)
  Product 2 lipidomics
Index term Index term Flagship Pioneering–Lipotype: lipid analysis, 201709c supply service lipid anaylsis for Flagship VentureLabs
Person Person Uecke, Oliver (Lipotype GmbH 201410 Head Business Development + Finance)


About the project

Lipotype performed lipid analysis for Flagship VentureLabs with the aim to better understand molecular compositions of chondrisomes, pharmaceutically active derivatives of mitochondria. The research of Flagship VentureLabs is on novel ways of preparation of chondrisomes that have beneficial structural characteristics, yield, concentration, stability, viability, integrity, or function. The lipidomic results facilitated the characterization of isolated chondrisomes in order to evaluate their quality and subsequently were used to file a recently published patent application.

Methods and Compositions of Chondrisomes – United States Patent Application 20170151287, 2017
G A Von Maltzahn, J M Milwid, M Mee, J R Rubens, D Chess, K Trudeau, K Mahdaviani, J Feala

Flagship Pioneering
Scientific ventures for life
Download PDF [pdf Version geholt als APPENDIX; ML]

Fueled by curiosity and a quest for new sources of future value, Flagship conceives, creates, resources and grows first-in-category life sciences companies. The unique, systematic, hypothesis-driven innovation process empowers Flagship simultaneously to explore the world’s biggest problems and to conceive disruptive scientific solutions. Flagship ventures deliver breakthrough medicines, maximize the potential of new agricultural practices, and power the world with innovative resources. At Flagship Pioneering, we deploy boundless curiosity and creativity within our institutional innovation foundry, VentureLabs. Flagship VentureLabs has originated more than 200 patents and 40 companies. These ventures establish entire new fields and uncover previously undiscovered areas of science. Some of our notable venture creation successes include Moderna Therapeutics, Seres Therapeutics, Axcella Health, Indigo Agriculture and Adnexus.

About Lipotype
Lipotype is a spin-off company from the Kai Simons and Andrej Shevchenko labs of the world-renowned Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden, Germany. Drawing on many years of cutting edge research experience, Lipotype delivers comprehensive, absolutely quantitative lipid analysis services for clinical and biological samples on a high-throughput scale. Lipotype offers high quality lipid analysis services for a wide range of customers and applications including biomarker identification for clinical researchers, pharma and biotech companies, functional food development for the food industry, claim support for the cosmetics industry, as well as for the small-scale profiling needs of academic researchers. 

For enquiries, please contact:
Lipotype GmbH
Oliver Uecke, Business Development | Tatzberg 47 | 01307 Dresden | Germany
T: +49 (0) 351 79653-45 |

Record changed: 2023-06-05


Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

More documents for Lipotype GmbH

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px

» top